Regulatory T cells and treatment of cancer
- 30 April 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 20 (2) , 241-246
- https://doi.org/10.1016/j.coi.2008.04.008
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejectionThe Journal of Experimental Medicine, 2008
- A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppressionNature Medicine, 2008
- Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanomaProceedings of the National Academy of Sciences, 2007
- Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancerBritish Journal of Cancer, 2007
- The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphomaProceedings of the National Academy of Sciences, 2007
- Melanoma Induces Immunosuppression by Up-Regulating FOXP3+ Regulatory T CellsJournal of Surgical Research, 2007
- The impact of regulatory T cells on carcinogen-induced sarcogenesisBritish Journal of Cancer, 2007
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 2006
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaThe Journal of Experimental Medicine, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006